Psoriasis is a common disease, which has a considerable impact on the healthcare system.
Therefore, appropriate use of therapeutic resources is very important. Management of …

Since the introduction of biologics for the treatment of rheumatoid arthritis (RA), psoriatic arthritis
(PsA), ankylosing spondylitis (AS), and psoriasis (Pso) an increased risk of tuberculosis (…

Minimally ablative fractional laser devices have gained acceptance as a preferred method
for skin resurfacing. Notable improvements in facial rhytides, photodamage, acne scarring, …

Melasma (cloasma) is a typical hypermelanosis and a common dermatologic skin disease
that involves sun-exposed areas of the skin. It mostly affects women of reproductive age. Solar …

… of data and writing manuscript; F. Prignano: patient selection and clinical assessment,
revision of manuscript; D. Bonciani: clinical assessment and collecting data; F. Bartoli: clinical …

Background The anti‐tumour necrosis factor (TNF)‐α adalimumab is the only licenced biologic
for moderate‐to‐severe hidradenitis suppurativa (HS). No predictors of response have …

Background Pruritus is an important symptom in psoriasis vulgaris, may be severe and
seriously affect the quality of life of patients, but published data on its frequency and …

Emotional tensions in predisposed subjects may play a key role in inducing a pruritic
sensation, leading to a scratching that, becoming a self‐perpetuating pathomechanism, may …

Background Psoriasis is a chronic hyperproliferative inflammatory skin disease, characterized
by a generalized redox imbalance. Anti-tumor necrosis factor (TNF)-α therapy is widely …

Introduction. Antitumor necrosis factor-alpha (TNF-α) agents are widely used for treatment of
rheumatic and dermatological diseases. We conducted the systematic review and meta-…